Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CTRE vs NHI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CTRE Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

CTRE Overall Winner 6-Pillar Tally: CTRE 5 – 1 NHI Matrix Metrics: CTRE 6 – 4 NHI

As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over National Health Investors (NHI) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CTRE carries a Unified Composite Score of 46.6/100 (HOLD) at $37.53 (22.3x Forward P/E, 66.2% operating margin), whereas NHI carries 31.7/100 (SELL) at $61.47 (18.2x Forward P/E, 42.5% operating margin).

  • Technical & Structure Timing Caution: CTRE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 52.3); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CTRE vs NHI
CTRE NYSE Head-to-Head Winner
CareTrust REIT, Inc
Real Estate Investment Trusts
$37.53
-1.42% 1D
Market Cap $9.8B
TTM Revenue $615M
Forward P/E 22.3x
Beta / 30D Vol 0.15β · 28% Vol
Unified Composite Score
46.6 / 100 HOLD
Tech 42.0 Fund 45.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.3 · SMA20: $37.15 · SMA50: $37.17
NHI NYSE
National Health Investors
Real Estate Investment Trusts
$61.47
-2.35% 1D
Market Cap $3.2B
TTM Revenue $459M
Forward P/E 18.2x
Beta / 30D Vol -0.21β · 34% Vol
Unified Composite Score
31.7 / 100 SELL
Tech 12.0 Fund 35.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 32
RSI-14: 32.2 · SMA20: $67.24 · SMA50: $67.11

6-Pillar Scorecard Institutional Category Breakdown (CTRE 5 – 1 NHI)

Columns: Metric · CTRE · NHI
1. Valuation Multiples NHI
Forward P/E 22.3x 18.2x
Trailing P/E 24.0x 4.6x
PEG Ratio 1.26x 4.76x
EV / Revenue 18.6x 6.9x
2. Growth & Scale CTRE
Revenue Growth (YoY) +33.2% +26.3%
Earnings Growth (YoY) -0.8% N/A
TTM Revenue (USD) $615M $459M
Market Cap $9.8B $3.2B
3. Profitability & Quality CTRE
Gross Margin 95.7% 71.2%
Operating Margin 66.2% 42.5%
Net Profit Margin 59.2% 151.8%
Return on Equity (ROE) 7.7% 38.6%
4. Balance Sheet & Cash Flow CTRE
Cash Generation (TTM) $485M $292M EBITDA
Cash Flow Margin 78.8% 63.5% EBITDA Mgn
Net Cash / Leverage $1.59B Net Debt (0.39x D/E) $42.56 Book/Sh · 38.6% ROE
Dividend Yield 3.90% 5.60%
5. Options & Positioning CTRE
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 24.7% (10th %ile) 19.1% (2nd %ile)
Put/Call OI Skew 6.12x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CTRE
OpEx & R&D Intensity 29.5% of Rev ($182M) 28.7% of Rev ($132M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CTRE (6) vs NHI (4)
Institutional Metric CTRE NHI Criterion Row Edge
Market Capitalization
Scale
$9.8B $3.2B Larger Scale CTRE
Trailing P/E Ratio
Valuation
24.0x 4.6x Lower Multiple NHI
Forward P/E Ratio
Valuation
22.3x 18.2x Lower Multiple NHI
Revenue Growth (YoY)
Growth
+33.2% +26.3% Higher Growth CTRE
Operating Margin (TTM)
Profitability
66.2% 42.5% Higher Margin CTRE
Net Profit Margin
Profitability
59.2% 151.8% Higher Margin NHI
Return on Equity (ROE)
Capital Efficiency
7.7% 38.6% Higher ROE NHI
52-Week Range Position
Momentum
31% ($35–$44) 0% ($61–$91) Stronger Trend CTRE
Beta / 30D Volatility
Risk Regime
0.15β · 28% Vol -0.21β · 34% Vol Lower Realized Risk CTRE
Unified Institutional Score
Composite Signal
46.6 / 100 (HOLD) 31.7 / 100 (SELL) Higher Composite CTRE
Trailing 12M Revenue (USD)
Operating Scale
$615M $459M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.7% 71.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.26x PEG · 18.6x EV/Rev 4.76x PEG · 6.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$485M ($1.59B Net Debt (0.39x D/E)) $292M EBITDA ($42.56 Book/Sh · 38.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CTRE +9.94 pp
CTRE: +2.68% · NHI: -7.26%
3M Horizon CTRE +11.57 pp
CTRE: -4.5% · NHI: -16.07%
6M Horizon CTRE +9.39 pp
CTRE: -9.61% · NHI: -19.0%
1Y Horizon CTRE +25.02 pp
CTRE: +5.01% · NHI: -20.01%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CTRE vs NHI. Trailing 12-month operating profitability (CTRE 66.2% vs NHI 42.5%) and valuation multiples (CTRE 22.3x vs NHI 18.2x Forward P/E) are benchmarked directly in Pillar 4 below.

CTRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$615M
Gross Margin95.7%
Op. Margin66.2%
ROE / Fwd P/E7.7% · 22.3x
NHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$459M
Gross Margin71.2%
Op. Margin42.5%
ROE / Fwd P/E38.6% · 18.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CTRE CONSOLIDATION
83d in phase · OBV DISTRIBUTION
Current IV 24.7%
IV Percentile 10th %ile
Put/Call OI Skew 6.12x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact CTRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NHI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 19.1%
IV Percentile 2nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CTRE Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $9.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment 29.5% of Rev ($182M)
90D Engineering Disclosures 0 Published
NHI Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.2B market capitalization and 42.5% operating margin.
OpEx & R&D Reinvestment 28.7% of Rev ($132M)
90D Engineering Disclosures 0 Published

Investor FAQ CTRE vs NHI Key Questions & Quantitative Answers

As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over National Health Investors (NHI) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CTRE carries a Unified Composite Score of 46.6/100 (HOLD) at $37.53 (22.3x Forward P/E, 66.2% operating margin), whereas NHI carries 31.7/100 (SELL) at $61.47 (18.2x Forward P/E, 42.5% operating margin). Technical & Structure Timing Caution: CTRE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 52.3); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CTRE leads the Growth & Scale pillar: CTRE posts +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin), compared with NHI at +26.3% YoY revenue growth and N/A YoY earnings growth on $459M TTM revenue (71.2% gross margin, 42.5% operating margin). On trailing 12-month operating scale, CTRE generates $615M in USD-normalized revenue versus $459M for NHI. In operating R&D and SG&A reinvestment, CTRE deploys 29.5% of Rev ($182M) (0 90-day corporate R&D disclosures) versus 28.7% of Rev ($132M) (0 disclosures) for NHI.

NHI screens cheaper on headline valuation multiples. CTRE trades at 22.3x Forward P/E, 24.0x Trailing P/E, 1.26x PEG, and 18.6x EV/Revenue (78.8% FCF margin), whereas NHI trades at 18.2x Forward P/E, 4.6x Trailing P/E, 4.76x PEG, and 6.9x EV/Revenue (63.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CTRE (7.7% ROE) versus NHI (38.6% ROE) capital efficiency.

In options market volatility and institutional positioning, CTRE carries 24.7% implied volatility (10th %ile, Compressed (<25th %ile)), a 6.12x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.15β · 28% Vol realized risk). By comparison, NHI carries 19.1% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.21β · 34% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.